Concepedia

David A. Cooper

DA

Statistics

Publications

10

Citations

631

H-Index

10

Active since

1988

Affiliations

St Vincent's Hospital Sydney(Current)

National Centre for Clinical Research on Emerging Drugs

UNSW Sydney

University Hospital Frankfurt

University College London

David A. Cooper is an author at St Vincent's Hospital Sydney specializing in antiretroviral therapy, infectious diseases, and life sciences.

Publications per year

1988–2024

10

Publications

10

Long-term symptomless HIV-1 infection in recipients of blood products from a single donor

Jennifer C. Learmont, B. Tindall, John Kaldor et al. · The Lancet · 1992 · 235 citations

, , +16

Lipodystrophy Associated with an HIV-Protease Inhibitor

Andrew Carr, David A. Cooper · New England Journal of Medicine · 1998 · 109 citations · Full text

, , +13

Severity and Prognosis of Acute Human Immunodeficiency Virus Type 1 Illness: A Dose‐Response Relationship

Philippe Vanhems, Jean Lambert, David A. Cooper et al. · Clinical Infectious Diseases · 1998 · 76 citations · Full text

, , +11

Sulphadiazine desensitization in patients with AIDS and cerebral toxoplasmosis

M Tenant‐Flowers, Michael Boyle, Dianne Carey et al. · AIDS · 1991 · 51 citations

, , +10

Pharmacokinetic study of saquinavir hard gel caps/ritonavir in HIV-1-infected patients: 1600/100 mg once-daily compared with 2000/100 mg once-daily and 1000/100 mg twice-daily

Reshma Autar, Jintanat Ananworanich, W. Apateerapong et al. · Journal of Antimicrobial Chemotherapy · 2004 · 41 citations · Full text

, , +17

1–5 of 10